Literature DB >> 12702271

Isolation and characterisation of the phospholipase B gene of Cryptococcus neoformans var. gattii.

G Nicolas Latouche1, Tania C Sorrell, Wieland Meyer.   

Abstract

Cryptococcus neoformans var. gattii (serotypes B and C) is a human pathogen, ecologically, biochemically, clinically and genetically different from C. neoformans var. grubii (serotype A) and C. neoformans var. neoformans (serotype D). The phospholipase B (PLB1) gene from serotypes B and C was isolated and characterised. It resembled the serotype A and D genes, with an overall sequence homology of more than 85%. The respective open reading frames were 2236 bp (serotype B) and 2239 bp (serotype C) in length. Each contained six introns and encoded a 68-kDa protein destined for secretion. PLB1 was located on the second smallest chromosome in both serotypes. Gene expression, measured as mRNA, was not regulated by temperature, pH or exogenous nutrients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12702271     DOI: 10.1111/j.1567-1364.2002.tb00122.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  13 in total

1.  Selection of optimal host strain for molecular pathogenesis studies on Cryptococcus gattii.

Authors:  Sudha Chaturvedi; Ping Ren; Srinivas D Narasipura; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

2.  PCR-restriction fragment length polymorphism analysis of the phospholipase B (PLB1) gene for subtyping of Cryptococcus neoformans isolates.

Authors:  G Nicolas Latouche; Matthew Huynh; Tania C Sorrell; Wieland Meyer
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

3.  Analysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains.

Authors:  Ashutosh Singh; Andrew MacKenzie; Geoffrey Girnun; Maurizio Del Poeta
Journal:  J Lipid Res       Date:  2017-08-15       Impact factor: 5.922

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor.

Authors:  Julianne T Djordjevic; Maurizio Del Poeta; Tania C Sorrell; Kylie M Turner; Lesley C Wright
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

6.  Proteomic profiling of the influence of iron availability on Cryptococcus gattii.

Authors:  Juliana Crestani; Paulo Costa Carvalho; Xuemei Han; Adriana Seixas; Leonardo Broetto; Juliana de Saldanha da Gama Fischer; Charley Christian Staats; Augusto Schrank; John R Yates; Marilene Henning Vainstein
Journal:  J Proteome Res       Date:  2011-10-26       Impact factor: 4.466

Review 7.  Phospholipase A2 and phospholipase B activities in fungi.

Authors:  Gerwald A Köhler; Audrey Brenot; Eric Haas-Stapleton; Nina Agabian; Rupal Deva; Santosh Nigam
Journal:  Biochim Biophys Acta       Date:  2006-10-03

8.  Cryptococcal phospholipases: a novel lysophospholipase discovered in the pathogenic fungus Cryptococcus gattii.

Authors:  Lesley C Wright; Jackie Payne; Rosemary T Santangelo; Mukoma F Simpanya; Sharon C A Chen; Fred Widmer; Tania C Sorrell
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

9.  Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada.

Authors:  James A Fraser; Ryan L Subaran; Connie B Nichols; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2003-10

10.  The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii.

Authors:  Popchai Ngamskulrungroj; Uwe Himmelreich; Julia A Breger; Christabel Wilson; Methee Chayakulkeeree; Mark B Krockenberger; Richard Malik; Heide-Marie Daniel; Dena Toffaletti; Julianne T Djordjevic; Eleftherios Mylonakis; Wieland Meyer; John R Perfect
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.